China National Medicines Corporation Ltd.

SHSE:600511 Stok Raporu

Piyasa değeri: CN¥27.3b

China National Medicines Yönetim

Yönetim kriter kontrolleri 0/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Guotao Tian

İcra Kurulu Başkanı

CN¥2.6m

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi2.5yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi1.9yrs
Yönetim Kurulu ortalama görev süresi2.6yrs

Son yönetim güncellemeleri

Recent updates

We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease

Nov 12
We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease

The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 25
The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Sep 26
China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Sep 10
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

Jul 28
Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

Jun 24
China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Jun 07
China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Is China National Medicines (SHSE:600511) Using Too Much Debt?

Jun 05
Is China National Medicines (SHSE:600511) Using Too Much Debt?

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

May 21
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

Apr 10
Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

China National Medicines (SHSE:600511) Could Easily Take On More Debt

Feb 28
China National Medicines (SHSE:600511) Could Easily Take On More Debt

CEO

Guotao Tian (53 yo)

2.5yrs

Görev süresi

CN¥2,550,000

Tazminat

Mr. Guotao Tian is GM & Director of China National Medicines Corporation Ltd. from April 07, 2022.


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Guotao Tian
GM & Director2.5yrsCN¥2.55mVeri yok
Fei Chen
Chief Financial Officer1.1yrsCN¥191.30kVeri yok
Lichun Luo
Board Secretary2.5yrsCN¥1.15mVeri yok
Zhang Ting
Deputy Secretary of the Party Committeeno dataCN¥371.90kVeri yok

1.9yrs

Ortalama Görev Süresi

46yo

Ortalama Yaş

Deneyimli Yönetim: 600511 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.9 yıl), bu da yeni bir ekibin varlığını gösteriyor.


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Guotao Tian
GM & Director2.6yrsCN¥2.55mVeri yok
Xiuchang Jiang
Chairman13.7yrsVeri yokVeri yok
Yong Liu
Director12.9yrsVeri yokVeri yok
Jingyun Liu
Chairman of the Supervisory Board12.9yrsVeri yokVeri yok
Luwen Shi
Independent Director2.6yrsCN¥200.00kVeri yok
Xingxi Yu
Independent Director2.6yrsCN¥200.00kVeri yok
Deyong Wen
Director5.5yrsVeri yokVeri yok
Xin Jiang
Director2.6yrsCN¥2.55mVeri yok
Xiaojuan Li
Director2.6yrsVeri yokVeri yok
Kai Lu
Supervisor2.6yrsVeri yokVeri yok

2.6yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 600511 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.6 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.